{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:39:30Z","timestamp":1787009970720,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Therapeutic drug monitoring (TDM) results for ganciclovir in 12 different treatment episodes showed large intraindividual and interindividual variabilities in the trough concentration and area under the 24-hour concentration\u2013time curve (AUC24). Despite adequate valganciclovir dosing, subtherapeutic concentrations were found in 30% of the treatment episodes. A decrease in viral load was observed regardless of subtherapeutic exposure. These findings show the need for target concentration evaluation and assessment of the applicability of ganciclovir TDM in children.<\/jats:p>","DOI":"10.1097\/ftd.0000000000001050","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T18:28:08Z","timestamp":1675362488000},"page":"269-272","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Subtherapeutic Exposure of Ganciclovir in Children Despite Appropriate Dosing: A Short Communication"],"prefix":"10.1097","volume":"45","author":[{"given":"Sjanene","family":"Marfil","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6478-1959","authenticated-orcid":false,"given":"Anne-Grete","family":"M\u00e4rtson","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands;"},{"name":"University of Liverpool, Antimicrobial Pharmacodynamics and Therapeutics, Liverpool, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlous","family":"Toren-Wielema","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coretta","family":"Leer-Buter","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Groningen, Department of Medical Microbiology and Infection Prevention ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth H.","family":"Sch\u00f6lvinck","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Department of Pediatric Infectious Diseases, Groningen, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem C.","family":"Alffenaar","sequence":"additional","affiliation":[{"name":"Sydney Institute of Infectious Diseases, the University of Sydney, Westmead ;"},{"name":"The University of Sydney, Sydney Pharmacy School, Faculty of Medicine and Health, Camperdown; and"},{"name":"Department of Pharmacy, Westmead Hospital, Westmead, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan J.","family":"Touw","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke G. G.","family":"Sturkenboom","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transpl."},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/tid.12456","article-title":"Occurrence of adverse events caused by valganciclovir as pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administration","volume":"17","author":"Takahata","year":"2015","journal-title":"Transpl Infect Dis."},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Amer J Transpl."},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/FTD.0000000000000925","article-title":"Therapeutic drug monitoring of ganciclovir: where are we?","volume":"44","author":"M\u00e4rtson","year":"2022","journal-title":"Ther Drug Monit."},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/jac\/dkab419","article-title":"Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads","volume":"77","author":"M\u00e4rtson","year":"2022","journal-title":"J Antimicrob Chemother."},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijantimicag.2010.11.033","article-title":"Ganciclovir treatment in children: evidence of subtherapeutic levels","volume":"37","author":"Luck","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/INF.0b013e3182463a19","article-title":"Pharmacokinetic profile of valganciclovir in pediatric transplant recipients","volume":"31","author":"Launay","year":"2012","journal-title":"Pediatr Infect Dis J."},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1399-3046.2006.00669.x","article-title":"Unexpectedly high inter- and intrapatient variability of Ganciclovir levels in children","volume":"11","author":"Vethamuthu","year":"2007","journal-title":"Pediatr Transpl."},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"e1922","DOI":"10.1128\/AAC.01192-19","article-title":"Population pharmacokinetics of ganciclovir after valganciclovir treatment in children with renal transplant","volume":"63","author":"Facchin","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/petr.12179","article-title":"New algorithm for valganciclovir dosing in pediatric solid organ transplant recipients","volume":"18","author":"\u00c5sberg","year":"2013","journal-title":"Pediatr Transpl."},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1517\/17425255.2015.988139","article-title":"Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection","volume":"11","author":"Stockmann","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1093\/jac\/dkab195","article-title":"Ganciclovir therapeutic drug monitoring in transplant recipients","volume":"76","author":"M\u00e4rtson","year":"2021","journal-title":"J Antimicrob Chemother."},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"175","DOI":"10.17145\/jab.18.022","article-title":"Determination of ganciclovir and acyclovir in human serum using liquid chromatography-tandem mass spectrometry","volume":"4","author":"M\u00e4rtson","year":"2018","journal-title":"J Appl Bioanal."},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"e2320","DOI":"10.1128\/AAC.02254-20","article-title":"Population Pharmacokinetics of intravenous Ganciclovir and oral Valganciclovir in pediatric population to optimize dosing regimens","volume":"65","author":"Nguyen","year":"2021","journal-title":"Antimicrob Agents Chemother."},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/petr.12030","article-title":"Valganciclovir dosing using area under the curve calculations in pediatric solid organ transplant recipients","volume":"17","author":"Villeneuve","year":"2013","journal-title":"Pediatr Transpl."},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/INF.0000000000001595","article-title":"Valganciclovir dosing for cytomegalovirus prophylaxis in pediatric solid-organ transplant recipients: a prospective pharmacokinetic study","volume":"36","author":"Peled","year":"2017","journal-title":"Pediatrinfect Dis J."},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.humimm.2004.02.012","article-title":"Cytomegalovirus (CMV)-specific cellular immune responses","volume":"65","author":"Harari","year":"2004","journal-title":"Hum Immunol."},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1600-6143.2008.02528.x","article-title":"Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients","volume":"9","author":"Vaudry","year":"2009","journal-title":"Am J Transplant."},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1399-3062.2009.00478.x","article-title":"Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients","volume":"12","author":"Pescovitz","year":"2009","journal-title":"Transpl Infect Dis."},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/cpt.2431","article-title":"Pharmacokinetics, pharmacodynamics, and therapeutic drug monitoring of valganciclovir and ganciclovir in transplantation","volume":"112","author":"Franck","year":"2022","journal-title":"Clin Pharmacol Ther."},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/01.TP.0000164512.99703.AD","article-title":"Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipients","volume":"79","author":"Wiltshire","year":"2005","journal-title":"Transplantation"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T13:17:51Z","timestamp":1748956671000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001050","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"assertion":[{"value":"2022-06-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}